- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07709975
Analgesia Methods and Early Mobilization in Geriatric ICU Patients After Major Surgery
Effect of Analgesia Methods on Early Mobilization and Patient Satisfaction in Geriatric Patients Admitted to Intensive Care After Major Surgery
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Early mobilization is a key component of enhanced postoperative recovery in older adults and has been associated with reduced functional decline, shorter intensive care unit (ICU) and hospital stays, and fewer postoperative complications. However, postoperative pain remains one of the main barriers to early mobilization. Although several analgesic strategies are routinely used after major surgery, their comparative effects on functional recovery in critically ill geriatric patients have not been well established in real-world clinical practice.
This is a prospective, single-center observational cohort study designed to evaluate the association between routinely administered postoperative analgesic techniques and early postoperative recovery in geriatric surgical patients requiring ICU admission. Because the study is observational, all perioperative and postoperative management, including the choice of analgesic technique, will be determined exclusively by the treating clinicians according to institutional practice. No treatment allocation, randomization, or protocol-driven intervention will be performed.
Clinical and perioperative data will be collected prospectively from routine medical records, anesthesia documentation, ICU electronic records, and nursing charts using standardized case report forms. Data quality will be ensured through predefined data collection procedures and verification before database entry. The study does not require any additional diagnostic tests, invasive procedures, blood sampling, or alterations to routine patient care.
The findings are expected to provide real-world evidence regarding the relationship between commonly used postoperative analgesic strategies and recovery after major surgery in older adults. These results may help optimize perioperative pain management protocols and support future comparative and interventional studies aimed at improving functional recovery in the geriatric surgical population.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Zekeriya Ervatan, MD
- Número de teléfono: +90505 598 32 48
- Correo electrónico: zek.ervatan@gmail.com
Ubicaciones de estudio
-
-
Istanbul
-
Istanbul, Istanbul, Turquía (Türkiye), 34384
- Reclutamiento
- University of Health Sciences, Prof. Dr. Cemil Taşçıoğlu City Hospital
-
Contacto:
- Zekeriya Ervatan, MD
- Número de teléfono: +90505 598 32 48
- Correo electrónico: zek.ervatan@gmail.com
-
Contacto:
- Beyzanur Aydoğdu, MD
- Número de teléfono: +90531 367 70 76
- Correo electrónico: beyzaaydogan7714@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Age 65 years or older
- ASA physical status classification I-IV
- Admitted to the intensive care unit (ICU) following major surgery
- ICU stay of at least 24 hours
Exclusion Criteria:
- Previously diagnosed advanced-stage dementia
- Inability to assess consciousness due to severe neurological deficit
- ICU stay of less than 24 hours
- Incomplete or insufficient clinical data
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Systemic Analgesia
Patients who receive systemic (intravenous) opioid analgesia, with or without multimodal analgesic agents, as determined by the treating clinical team.
|
Standard-of-care intravenous opioid-based analgesia, with or without additional non-opioid multimodal agents, administered per routine clinical practice.
|
|
Epidural Analgesia
Patients who receive epidural analgesia as determined by the treating clinical team.
|
Standard-of-care epidural analgesia administered per routine clinical practice.
|
|
Peripheral Nerve Block
Patients who receive peripheral nerve block analgesia, with or without multimodal analgesic agents, as determined by the treating clinical team.
|
Standard-of-care peripheral nerve block analgesia, with or without additional non-opioid multimodal agents, administered per routine clinical practice.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time to First Mobilization
Periodo de tiempo: From ICU admission until first achievement of ICU Mobility Scale level ≥1, assessed for up to 30 days.
|
Time (in hours) from ICU admission to the first time the patient achieves at least one level of mobilization - sitting at the bedside, standing, or walking - based on the ICU Mobility Scale.
|
From ICU admission until first achievement of ICU Mobility Scale level ≥1, assessed for up to 30 days.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Postoperative Pain Score
Periodo de tiempo: At ICU admission, and at 6, 12, 24, and 48 hours after ICU admission
|
Pain intensity assessed using the Numeric Rating Scale (0 = no pain, 10 = worst possible pain).
|
At ICU admission, and at 6, 12, 24, and 48 hours after ICU admission
|
|
Incidence of Delirium
Periodo de tiempo: Assessed at least once daily for the first 3 days of ICU stay
|
Presence of delirium assessed using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU), reported as positive or negative.
|
Assessed at least once daily for the first 3 days of ICU stay
|
|
Length of ICU Stay
Periodo de tiempo: From ICU admission to ICU discharge, up to approximately 30 days
|
Total number of days the patient remains in the intensive care unit.
|
From ICU admission to ICU discharge, up to approximately 30 days
|
|
Total Opioid Consumption
Periodo de tiempo: From ICU admission to ICU discharge, up to approximately 30 days
|
Cumulative opioid dose administered, expressed as morphine milligram equivalents (mg).
|
From ICU admission to ICU discharge, up to approximately 30 days
|
|
Patient Satisfaction with Analgesia
Periodo de tiempo: Assessed once, prior to ICU discharge
|
Patient-reported satisfaction with pain management assessed using a 5-point Likert scale (1 = very dissatisfied, 5 = very satisfied).
|
Assessed once, prior to ICU discharge
|
|
Incidence and Type of Postoperative Complications
Periodo de tiempo: From ICU admission to ICU discharge, up to approximately 30 days
|
Presence and type of any postoperative complications recorded during ICU stay.
|
From ICU admission to ICU discharge, up to approximately 30 days
|
Colaboradores e Investigadores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Dolor
- Manifestaciones neurológicas
- Enfermedades del Sistema Nervioso
- Desordenes mentales
- Complicaciones Postoperatorias
- Procesos Patológicos
- Confusión
- Manifestaciones neuroconductuales
- Trastornos neurocognitivos
- Condiciones Patológicas, Signos y Síntomas
- Comportamiento
- Signos y síntomas
- Adherencia y Cumplimiento del Tratamiento
- Comportamiento de salud
- Fragilidad
- Delirio de emergencia
- Dolor Postoperatorio
- Delirio
- Satisfacción del paciente
- Anestesia y analgesia
- Analgesia
- Analgesia, epidural
Otros números de identificación del estudio
- CT-ERHO-AR-BA-04
- E-48670771-514.99-316163880 (Otro identificador: University of Health Sciences Prof. Dr. Cemil Taşçıoğlu City Hospital Clinical Research Ethics Committee)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .